Yun Yen

Position	Company	Period
Director	Lixte Biotechnology Holdings Inc	Aug. 4, 2018 -
Independent Director	Fulgent Genetics Inc	Sept. 1, 2016 -

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value	Details
2020-12-04	2020-11-30	Lixte Biotechnology Holdings Inc (LIXT)	B Purchase	85,058 -37.1% 12.31 US$4,590,732	85,058 -37.1%	12.31	US$4,590,732